{"database": "lobbying", "table": "lobbying_activities", "rows": [[3013677, "f9e61ef5-ab9a-4915-8a2e-b3716a095aa4", "Q2", "THE ALS ASSOCIATION", 401104947, "THE ALS ASSOCIATION", 2023, "second_quarter", "PHA", "Promising Pathways Act (S.1906) - Discussion around a provisional approval path for drugs and biological interventions that meet unmet needs of rare diseases like ALS.", "HOUSE OF REPRESENTATIVES,SENATE", null, 25000, 0, 0, "2023-07-19T10:13:29-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3013677"], "units": {}, "query_ms": 531.3233769265935, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}